Business Results for Fiscal 2022
May 10, 2023
TSUMURA & CO.
1
Agenda
01 |
02 |
Business Results for Fiscal 2022 and Earnings Forecast for Fiscal 2023
Outlook for China Business
2
2
Business Results for Fiscal 2022 and Earnings Forecast for Fiscal 2023
Director, and CFO
Muneki Handa
Hello, my name is Muneki Handa.
I would like to start by thanking everyone participating here today for their constant support of Tsumura and its activities to promote the use of Kampo.
I would like to start today's presentation by explaining our business results for FY 2022 and our earnings forecast for FY 2023.
3
Agenda
01
FY 2022 Business Results Overview
4
Firstly, I will give an overview of business results in FY 2022.
4
Roadmap for the Realization of the TSUMURA VISION "Cho-WA" 2031
Prescription Kampo
Products
1st stage
FY2022-2024
-Germination-
Standardization of Kampo |
treatments |
Personalized Kampo |
treatments |
Personalized Kampo |
2nd stage
FY2025-2027
-Growth-
Over 50% physicians write 10 or more Kampo prescriptions
3rd stage
FY2028-2031
-Flowering-
50% of physicians write basic |
prescriptions in all treatment areas |
R&D
Formulation | |
platform | |
China | |
Crude drug | |
Business | platform |
Research | |
platform | |
Smart factory | |
Sales | |
Labor | |
productivity | Production |
Crude drugs | |
treatments | Research |
Scientific study of pre- | |
symptomatic diseases |
Traditional Chinese | Market |
medical products business | entry |
Crude drugs, drug pieces and | Sales |
Yakushokudogen products | expansion |
Traditional Chinese Medicine | Establishment |
Research Center |
Expand scope of
automation
Sales per MR (Yen/MR)
Physical labor productivity
Personnel expenses per crude drug arranging volume
Development
Build
foundations
Establish brands
Function expansion
Shift to oversight/management
Social
implementation
Establish brands
Lead industry development
Evidence-building for traditional
Chinese medical products
Realize smart factories
Double productivity | |
(vs. FY2021) | 5 |
This is our roadmap we announced in May 2022 for realizing the TSUMURA VISION "Cho-WA" 2031.
The First Medium-Term Management Plan, which spans the three fiscal years up to FY 2024, is positioned as a stage for conducting upfront investments and building foundations to realize our vision.
5